#Multiple myeloma

A Multiple Myeloma Cancer Diary

REGN5459 had decreased binding affinity to T cells, resulting in an encouraging side effect profile and efficacy.

Check out these advances in blood cancer research and treatment.

Newly FDA-approved drugs for ovarian, bladder, liver cancer, and more.

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.

Immunotherapy leads the way, along with promising breakthroughs for treating leukemia and multiple myeloma.

People who followed a protective diet and those on a standard hospital diet had a similar likelihood of infections.

Nearly a quarter of patients treated with the peptide-drug conjugate experienced partial remission.

Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.

UPDATE: On October 25, the FDA approved Tecvayli (teclistamab) to treat some people with multiple myeloma.

An experimental drug saved his life and inspire him to connect others with cancer to bone marrow transplants and clinical trials.

After treatment for multiple myeloma, Bryon Daily pays it forward to other African Americans, who are at higher risk for this cancer.

It’s a different life—cancer changes you—but it can be a good one.

People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.

There are many ways to get smarter in this issue.

Kellie Smith, 52, lives in Austin with her husband and child. She has multiple myeloma.

98% of people who received the customized immunotherapy responded to the one-time treatment.